NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/24/2022
Back to search
Official data from USPTO
TRANSCATHETER CARDIOVASCULAR THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRANSCATHETER CARDIOVASCULAR THERAPEUTICS
ST13
US500000075923652Class
41, 42
Filing
75923652
Registration
2526755
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
03/24/2022
Trademark type
Word
Nice classes
41, 42
Filing date
02/22/2000
Registration date
01/08/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2022
Last transaction
03/24/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/10/1988
First use in commerce
11/10/1988
Drawing code
1
Owner type
03
Owner location
New York, NY
Examiner
YONTEF, DAVID
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
C. F. (pessoa física)
Representatives
THOMAS J. KOWALSKI DUANE MORRIS LLP
Technical classification
Nice Classes
Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Educational servicesconducting symposiums in the field of medicine and the distribution of course materials in connection therewith
Class 42
Cardiovascular research
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/24/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/24/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/24/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/16/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/14/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/14/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/08/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/06/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/06/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/06/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/22/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
01/04/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/26/2008
PLGL
ASSIGNED TO PARALEGAL
01/22/2008
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
01/09/2008
PAPER RECEIVED
01/09/2008
CFIT
CASE FILE IN TICRS
04/17/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
01/08/2002
PUBO
PUBLISHED FOR OPPOSITION
10/16/2001
NPUB
NOTICE OF PUBLICATION
09/26/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2001
CNRT
NON-FINAL ACTION MAILED
08/11/2000
DOCK
ASSIGNED TO EXAMINER
07/24/2000
Continuous trademark protection
Get notified about every new filing that threatens TRANSCATHETER CARDIOVASCULAR THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.